| 摘要 |
<p>The present invention relates to a vaccine composition comprising the peptides SEQ ID NO: 3, SEQ ID NO: 6, SEQ ID NO: 11 and SEQ ID NO: 18, wherein the terminal ends of the sequences may be free carboxyl- or amino groups, amides, acetyls or salts thereof, together with a pharmaceutically acceptable diluent and optionally an adjuvant, carrier and/or vehicle and optionally additional immunostimulatory compound(s).</p> |
